Overjet, a Boston, Massachusetts -based dental AI startup based in Boston, has raised $42.5 million in Series B funding to revolutionize dental healthcare by using AI to improve patient care.
The oversubscribed round was co/led by General Catalyst and Insight Partners, with participation from existing investors Crosslink Capital and MIT-affiliated E14 Fund.
The capital brings the total funding raised by the startup to about $80 million after closing a $27 million Series A round back in August. Lonne Jaffe, Managing Director at Insight Partners.
Company: Overjet, Inc
Round: Series B
Funding Month: December 2021
Lead Investors: General Catalyst and Insight Partners
Additional Investors: Crosslink Capital and MIT-affiliated E14 Fund
Company Website: https://www.overjet.ai/
Software Category: dental artificial intelligence (AI) software
About the Company: Founded in 2018, Overjet is a software company that develops a platform designed to reduce costs and improve the quality of dental care. It uses artificial intelligence and analyzes dental data to determine what treatments are necessary for the patient, enabling patients to get improved dental care. Its computer vision and machine learning algorithms empower dental providers and payers to deliver patient care. Overjet has experienced rapid growth over the past years by serving over 16 major carriers to cover over 73 million Americans and expanding its team to 60 employees, which the startup plans to double by the next 6 months. The startup has also secured FDA clearance for its flagship product, becoming the first dental AI company to do so. Overjet cutting-edge artificial intelligence technology encodes dentist-level training and analysis into scalable software tools. Today, Overjet flagship products are used by some of the country’s largest insurance companies, dental support organizations, and dental practices to enable the best patient care.